At the end of @ weeks , there were significantly greater percentages of responders in groups given medium-dose OBS ( @ % , P = @ ) and high-dose OBS ( @ % , P = @ ) than in the group given placebo ( @ % ) ; there was no significant difference in percentages of responders between the low-dose OBS ( @ % ) and placebo groups ( P = @ ) .